Paper35239089
Pre-treatment circulating reproductive hormones levels predict pathological and survival outcomes in breast cancer submitted to neoadjuvant chemotherapy.
Lan A and 9 others. Int J Clin Oncol, 2022. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Pre-treatment circulating reproductive hormones levels predict pathological and survival outcomes in breast cancer submitted to neoadjuvant chemotherapy. Papers, record 35239089. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35239089
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pre-treatment circulating reproductive hormones levels predict pathological and survival outcomes in breast cancer submitted to neoadjuvant chemotherapy.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Neoadjuvant Therapy | Major topic |
| Antineoplastic Combined Chemotherapy Protocols | |
| Chemotherapy, Adjuvant | |
| Disease-Free Survival | |
| Female | |
| Follicle Stimulating Hormone | |
| Humans | |
| Progesterone | |
| Retrospective Studies | |
| Testosterone |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 81772979 | National Natural Science Foundation of China | PubMed | ||
| 81472658 | National Natural Science Foundation of China | PubMed |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14710223 | Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study. | Br J Cancer | 2004 | https://conductscience.org/library/papers/14710223 | PubMed |
| 2 | 133306 | Ovarian and adrenal contributions to peripheral steroid levels in postmenopausal women. | Obstet Gynecol | 1976 | https://conductscience.org/library/papers/133306 | PubMed |
| 3 | 20961245 | Expression of follicle-stimulating hormone receptor in tumor blood vessels. | N Engl J Med | 2010 | https://conductscience.org/library/papers/20961245 | PubMed |
| 4 | 24074790 | Sex hormones and breast cancer risk and prognosis. | Breast | 2013 | https://conductscience.org/library/papers/24074790 | PubMed |
| 5 | 11350888 | Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer. | Clin Cancer Res | 2001 | https://conductscience.org/library/papers/11350888 | PubMed |
| 6 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 7 | 11959894 | Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. | J Natl Cancer Inst | 2002 | https://conductscience.org/library/papers/11959894 | PubMed |
| 8 | 25581441 | PET of follicle-stimulating hormone receptor: broad applicability to cancer imaging. | Mol Pharm | 2015 | https://conductscience.org/library/papers/25581441 | PubMed |
| 9 | 27435394 | Follicle-Stimulating Hormone Receptor Is Expressed by Most Ovarian Cancer Subtypes and Is a Safe and Effective Immunotherapeutic Target. | Clin Cancer Res | 2017 | https://conductscience.org/library/papers/27435394 | PubMed |
| 10 | 23283524 | Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up. | Breast Cancer Res Treat | 2013 | https://conductscience.org/library/papers/23283524 | PubMed |
| 11 | 29895278 | Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients. | BMC Cancer | 2018 | https://conductscience.org/library/papers/29895278 | PubMed |
| 12 | 16322344 | Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. | Endocr Relat Cancer | 2005 | https://conductscience.org/library/papers/16322344 | PubMed |
| 13 | 1674070 | Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. | Lancet | 1991 | https://conductscience.org/library/papers/1674070 | PubMed |
| 14 | 19903744 | Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study. | Endocr Relat Cancer | 2010 | https://conductscience.org/library/papers/19903744 | PubMed |
| 15 | 28527781 | Steroid metabolism in breast cancer: Where are we and what are we missing? | Mol Cell Endocrinol | 2018 | https://conductscience.org/library/papers/28527781 | PubMed |
| 16 | 23688201 | Expression of follicle-stimulating hormone receptor by the vascular endothelium in tumor metastases. | BMC Cancer | 2013 | https://conductscience.org/library/papers/23688201 | PubMed |
| 17 | 29132557 | Triple-Negative Breast Cancer: Who Should Receive Neoadjuvant Chemotherapy? | Surg Oncol Clin N Am | 2018 | https://conductscience.org/library/papers/29132557 | PubMed |
| 18 | 21709140 | Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. | Ann Oncol | 2011 | https://conductscience.org/library/papers/21709140 | PubMed |
| 19 | 21670457 | Single-injection depot progesterone before surgery and survival in women with operable breast cancer: a randomized controlled trial. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21670457 | PubMed |
| 20 | 31512725 | Progesterone and Breast Cancer. | Endocr Rev | 2020 | https://conductscience.org/library/papers/31512725 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 36117838 | Association of serum reproductive hormones changes after neoadjuvant chemotherapy with hormone receptors expression alterations and survival outcomes in breast cancer. | Front Surg | 2022 | https://conductscience.org/library/papers/36117838 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35239089
GET https://conductscience.org/api/papers/v1/35239089/references?page=2